Immunitybio Stock Forecast - Simple Moving Average
| IBRX Stock | USD 5.97 0.24 3.86% |
Immunitybio Stock outlook is based on your current time horizon.
The RSI of Immunitybio's share price is above 70 at this time. This usually indicates that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Immunitybio, making its price go up or down. Momentum 71
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.11) | EPS Estimate Current Year (0.40) | EPS Estimate Next Year (0.26) | Wall Street Target Price 11.4 | EPS Estimate Current Quarter (0.10) |
Using Immunitybio hype-based prediction, you can estimate the value of Immunitybio from the perspective of Immunitybio response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Immunitybio using Immunitybio's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Immunitybio using crowd psychology based on the activity and movement of Immunitybio's stock price.
Immunitybio Short Interest
An investor who is long Immunitybio may also wish to track short interest. As short interest increases, investors should be becoming more worried about Immunitybio and may potentially protect profits, hedge Immunitybio with its derivative instruments, or be ready for some potential downside.
200 Day MA 2.6005 | Short Percent 0.3646 | Short Ratio 8.61 | Shares Short Prior Month 109 M | 50 Day MA 2.6658 |
Immunitybio Relative Strength Index
The Simple Moving Average forecasted value of Immunitybio on the next trading day is expected to be 6.09 with a mean absolute deviation of 0.21 and the sum of the absolute errors of 12.60.Immunitybio Hype to Price Pattern
Investor biases related to Immunitybio's public news can be used to forecast risks associated with an investment in Immunitybio. The trend in average sentiment can be used to explain how an investor holding Immunitybio can time the market purely based on public headlines and social activities around Immunitybio. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Immunitybio's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Immunitybio.
Immunitybio Implied Volatility | 1.6 |
Immunitybio's implied volatility exposes the market's sentiment of Immunitybio stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Immunitybio's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Immunitybio stock will not fluctuate a lot when Immunitybio's options are near their expiration.
The Simple Moving Average forecasted value of Immunitybio on the next trading day is expected to be 6.09 with a mean absolute deviation of 0.21 and the sum of the absolute errors of 12.60. Immunitybio after-hype prediction price | USD 6.42 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Immunitybio | Build AI portfolio with Immunitybio Stock |
Prediction based on Rule 16 of the current Immunitybio contract
Based on the Rule 16, the options market is currently suggesting that Immunitybio will have an average daily up or down price movement of about 0.1% per day over the life of the 2026-04-17 option contract. With Immunitybio trading at USD 5.97, that is roughly USD 0.00597 . If you think that the market is fully incorporating Immunitybio's daily price movement you should consider acquiring Immunitybio options at the current volatility level of 1.6%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Immunitybio Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Immunitybio's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Immunitybio's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Immunitybio stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Immunitybio's open interest, investors have to compare it to Immunitybio's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Immunitybio is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Immunitybio. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Immunitybio Additional Predictive Modules
Most predictive techniques to examine Immunitybio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Immunitybio using various technical indicators. When you analyze Immunitybio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Immunitybio Simple Moving Average Price Forecast For the 28th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Immunitybio on the next trading day is expected to be 6.09 with a mean absolute deviation of 0.21, mean absolute percentage error of 0.19, and the sum of the absolute errors of 12.60.Please note that although there have been many attempts to predict Immunitybio Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Immunitybio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Immunitybio Stock Forecast Pattern
| Backtest Immunitybio | Immunitybio Price Prediction | Buy or Sell Advice |
Immunitybio Forecasted Value
In the context of forecasting Immunitybio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Immunitybio's downside and upside margins for the forecasting period are 0.06 and 14.32, respectively. We have considered Immunitybio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Immunitybio stock data series using in forecasting. Note that when a statistical model is used to represent Immunitybio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.7844 |
| Bias | Arithmetic mean of the errors | -0.0933 |
| MAD | Mean absolute deviation | 0.2136 |
| MAPE | Mean absolute percentage error | 0.0572 |
| SAE | Sum of the absolute errors | 12.605 |
Predictive Modules for Immunitybio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immunitybio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Immunitybio After-Hype Price Density Analysis
As far as predicting the price of Immunitybio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Immunitybio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Immunitybio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Immunitybio Estimiated After-Hype Price Volatility
In the context of predicting Immunitybio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Immunitybio's historical news coverage. Immunitybio's after-hype downside and upside margins for the prediction period are 0.32 and 14.65, respectively. We have considered Immunitybio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Immunitybio is unstable at this time. Analysis and calculation of next after-hype price of Immunitybio is based on 3 months time horizon.
Immunitybio Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Immunitybio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immunitybio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Immunitybio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.88 | 8.23 | 0.11 | 0.29 | 8 Events / Month | 8 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
5.97 | 6.42 | 3.38 |
|
Immunitybio Hype Timeline
Immunitybio is currently traded for 5.97. The entity has historical hype elasticity of -0.11, and average elasticity to hype of competition of 0.29. Immunitybio is projected to increase in value after the next headline, with the price projected to jump to 6.42 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 3.38%, whereas the daily expected return is currently at 1.88%. The volatility of related hype on Immunitybio is about 5309.68%, with the expected price after the next announcement by competition of 6.26. Immunitybio currently holds 504.17 M in liabilities. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Historical Fundamental Analysis of Immunitybio to cross-verify your projections.Immunitybio Related Hype Analysis
Having access to credible news sources related to Immunitybio's direct competition is more important than ever and may enhance your ability to predict Immunitybio's future price movements. Getting to know how Immunitybio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Immunitybio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RCUS | Arcus Biosciences | (0.04) | 10 per month | 4.11 | 0.08 | 6.88 | (6.93) | 21.81 | |
| DNLI | Denali Therapeutics | (0.10) | 9 per month | 3.15 | 0.07 | 6.50 | (5.65) | 23.32 | |
| ETNB | 89bio Inc | (0.01) | 6 per month | 1.83 | 0.09 | 3.02 | (4.66) | 86.02 | |
| COGT | Cogent Biosciences | 0.32 | 9 per month | 2.38 | 0.13 | 5.94 | (4.91) | 126.24 | |
| GLPG | Galapagos NV ADR | 0.11 | 38 per month | 1.24 | 0.05 | 2.62 | (2.52) | 7.08 | |
| BEAM | Beam Therapeutics | (0.52) | 11 per month | 3.66 | 0.02 | 8.12 | (6.30) | 31.78 | |
| RXRX | Recursion Pharmaceuticals | 0.19 | 7 per month | 0.00 | (0.1) | 7.59 | (6.19) | 17.21 | |
| LQDA | Liquidia Technologies | 0.99 | 9 per month | 3.24 | 0.22 | 8.00 | (4.84) | 19.63 | |
| AGIO | Agios Pharm | 0.28 | 9 per month | 0.00 | (0.05) | 5.99 | (3.94) | 56.88 | |
| VRDN | Viridian Therapeutics | 0.33 | 9 per month | 1.88 | 0.15 | 5.57 | (2.22) | 15.86 |
Other Forecasting Options for Immunitybio
For every potential investor in Immunitybio, whether a beginner or expert, Immunitybio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Immunitybio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Immunitybio. Basic forecasting techniques help filter out the noise by identifying Immunitybio's price trends.Immunitybio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immunitybio stock to make a market-neutral strategy. Peer analysis of Immunitybio could also be used in its relative valuation, which is a method of valuing Immunitybio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Immunitybio Market Strength Events
Market strength indicators help investors to evaluate how Immunitybio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunitybio shares will generate the highest return on investment. By undertsting and applying Immunitybio stock market strength indicators, traders can identify Immunitybio entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 5.97 | |||
| Day Typical Price | 5.97 | |||
| Price Action Indicator | (0.12) | |||
| Period Momentum Indicator | (0.24) | |||
| Relative Strength Index | 71.25 |
Immunitybio Risk Indicators
The analysis of Immunitybio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Immunitybio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting immunitybio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.12 | |||
| Semi Deviation | 4.12 | |||
| Standard Deviation | 7.98 | |||
| Variance | 63.76 | |||
| Downside Variance | 23.18 | |||
| Semi Variance | 16.98 | |||
| Expected Short fall | (6.61) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Immunitybio
The number of cover stories for Immunitybio depends on current market conditions and Immunitybio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Immunitybio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Immunitybio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Immunitybio Short Properties
Immunitybio's future price predictability will typically decrease when Immunitybio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Immunitybio often depends not only on the future outlook of the potential Immunitybio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immunitybio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 700.4 M | |
| Cash And Short Term Investments | 149.8 M |
Additional Tools for Immunitybio Stock Analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.